CEO Sells Millions in Cardinal Health Stock

Deborah Weitzman, CEO of Cardinal Health's PSS Segment, recently divested 7,354 shares of the company's stock. This significant sale, executed at a weighted average price of $235.45, effectively reduced Weitzman's direct share ownership by 9%. Following the transaction, the executive retained 77,901 shares, which held a market value of $18.31 million as of August 18.

Cardinal Health, a prominent global integrated provider of healthcare products and services, operates with a substantial market capitalization of $55.0 billion. The Dublin-based firm's financial standing is further underscored by its trailing twelve-month revenue of $254.2 billion. The company's operations span pharmaceutical distribution and medical product services across multiple international markets.